Among them, CD8+T cells, which have demonstrated the greatest efficacy in tumor eradication (65, 66), exhibited a marked reduction in the high S100A2 expression group, providing a partial explanation for the unfavorable prognosis observed in patients with high S100A2 expression (64). The gene discussed is S100A2; the disease is neoplasm.